Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lennar A | LEN | Nov 22, 2024 | 169.17 | +0.65 |
Lennar B | LEN-B | Nov 22, 2024 | 160.49 | +0.83 |
Lennox International | LII | Nov 22, 2024 | 657.69 | +1.09 |
LENSAR | LNSR | Nov 22, 2024 | 7.38 | -0.94 |
LENZ Therapeutics | LENZ | Nov 22, 2024 | 35.50 | +3.44 |
Leonardo DRS | DRS | Nov 22, 2024 | 36.25 | +1.54 |
Lesaka Technologies | LSAK | Nov 22, 2024 | 5.26 | -0.75 |
Leslies | LESL | Nov 22, 2024 | 3.19 | +11.15 |
Levi Strauss & Co A | LEVI | Nov 22, 2024 | 16.32 | +2.19 |
Lexaria Bioscience | LEXX | Nov 22, 2024 | 2.09 | -3.24 |
Lexeo Therapeutics | LXEO | Nov 22, 2024 | 6.47 | +4.35 |
Lexicon Pharmaceuticals | LXRX | Nov 22, 2024 | 0.86 | +11.88 |
LexinFintech ADR | LX | Nov 22, 2024 | 3.39 | +2.73 |
LG Display ADR | LPL | Nov 22, 2024 | 3.45 | -1.71 |
LGI Homes | LGIH | Nov 22, 2024 | 105.82 | +3.01 |
LGL Group | LGL | Nov 22, 2024 | 6.00 | -2.44 |
Li Auto ADR | LI | Nov 22, 2024 | 22.28 | -1.42 |
Li Bang International | LBGJ | Nov 22, 2024 | 3.70 | 0.00 |
Li-Cycle | LICY | Nov 22, 2024 | 2.15 | +3.37 |
Liberty Allstar Equity Fund | USA | Nov 22, 2024 | 7.29 | +1.39 |
Liberty Allstar Growth Fund | ASG | Nov 22, 2024 | 5.79 | +1.05 |
Liberty Broadband A | LBRDA | Nov 22, 2024 | 86.29 | +0.45 |
Liberty Broadband A Pref | LBRDP | Nov 22, 2024 | 23.95 | +0.02 |
Liberty Broadband C | LBRDK | Nov 22, 2024 | 86.92 | +0.50 |
Liberty Global A | LBTYA | Nov 22, 2024 | 13.32 | +0.45 |
Liberty Global B | LBTYB | Nov 22, 2024 | 13.18 | +1.15 |
Liberty Global C | LBTYK | Nov 22, 2024 | 13.70 | +1.48 |
Liberty Global Class B | LBYAV | Nov 22, 2024 | 10.89 | 0.00 |
Liberty Latin America | LILAK | Nov 22, 2024 | 7.04 | +1.00 |
Liberty Latin America | LILA | Nov 22, 2024 | 7.11 | +0.99 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.